Brief: Zelira Therapeutics Raises A$1.77 Mln From U.S.-Based Investors
15/03/2023 01:16
March 15 (Reuters) - Zelira Therapeutics Ltd ZLD.AX :
* A$1.77 MILLION RAISED FROM US-BASED INVESTORS AT A$1 PER
SHARE
Source text for Eikon: ID:nASX5swVPC
Further company coverage: ZLD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zelira Therapeutics
See all newsBrief: Zelira Therapeutics Announces $33 MLN Fundraising Into Zeliras HOPE 1 SPV
Australia's Zelira Therapeutics surges on $33 million funding for drug trial
Australia's Zelira Therapeutics climbs to over 7-month high on securing patents
Brief: Zelira Therapeutics Receives USD$1.4 Million Unsecured Loan Funds From Chairman
Brief: Zelira Therapeutics Ltd Says Zld Secures Us$1.4M Unsecured Chairman Loan Facility